↓ Skip to main content

Heat: A Highly Efficient Skin Enhancer for Transdermal Drug Delivery

Overview of attention for article published in Frontiers in Bioengineering and Biotechnology, February 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Readers on

mendeley
205 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Heat: A Highly Efficient Skin Enhancer for Transdermal Drug Delivery
Published in
Frontiers in Bioengineering and Biotechnology, February 2018
DOI 10.3389/fbioe.2018.00015
Pubmed ID
Authors

Sabine Szunerits, Rabah Boukherroub

Abstract

Advances in materials science and bionanotechnology have allowed the refinements of current drug delivery systems, expected to facilitate the development of personalized medicine. While dermatological topical pharmaceutical formulations such as foams, creams, lotions, gels, etc., have been proposed for decades, these systems target mainly skin-based diseases. To treat systemic medical conditions as well as localized problems such as joint or muscle concerns, transdermal delivery systems (TDDSs), which use the skin as the main route of drug delivery, are very appealing. Over the years, these systems have shown to offer important advantages over oral as well as intravenous drug delivery routes. Besides being non-invasive and painless, TDDSs are able to deliver drugs with a short-half-life time more easily and are well adapted to eliminate frequent administrations to maintain constant drug delivery. The possibility of self-administration of a predetermined drug dose at defined time intervals makes it also the most convenient personalized point-of-care approach. The transdermal market still remains limited to a narrow range of drugs. While small and lipophilic drugs have been successfully delivered using TDDSs, this approach fails to deliver therapeutic macromolecules due to size-limited transport across thestratum corneum, the outermost layer of the epidermis. The low permeability of thestratum corneumto water-soluble drugs as well as macromolecules poses important challenges to transdermal administration. To widen the scope of drugs for transdermal delivery, new procedures to enhance skin permeation to hydrophilic drugs and macromolecules are under development. Next to iontophoresis and microneedle-based concepts, thermal-based approaches have shown great promise to enhance transdermal drug delivery of different therapeutics. In this inaugural article for the section "Frontiers in Bioengineering and Biotechnology," the advances in this field and the handful of examples of thermal technologies for local and systemic transdermal drug delivery will be discussed and put into perspective.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 205 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 205 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 26 13%
Student > Bachelor 26 13%
Researcher 23 11%
Student > Master 16 8%
Student > Postgraduate 8 4%
Other 29 14%
Unknown 77 38%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 32 16%
Engineering 17 8%
Medicine and Dentistry 15 7%
Chemistry 13 6%
Biochemistry, Genetics and Molecular Biology 9 4%
Other 27 13%
Unknown 92 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 May 2023.
All research outputs
#3,234,855
of 23,758,679 outputs
Outputs from Frontiers in Bioengineering and Biotechnology
#426
of 7,295 outputs
Outputs of similar age
#81,877
of 477,934 outputs
Outputs of similar age from Frontiers in Bioengineering and Biotechnology
#6
of 37 outputs
Altmetric has tracked 23,758,679 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,295 research outputs from this source. They receive a mean Attention Score of 3.5. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 477,934 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.